BridgeMD
Compares treatment options for Infection Control / Methods
Official title Preoperative Clindamycin Vaginal Cream Versus Vaginal Cleansing With Povidone-iodine on Postoperative Infections After Cesarean Section
ClinicalTrials.gov ID: NCT07474194
What this study is testing
What is Clindamycin vaginal cream?
Clindamycin vaginal cream is an investigational medicine, given as an infusion into a vein, being studied as a potential treatment for infection control / methods.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- To evaluate the effects of preoperative prophylactic administration of clindamycin vaginal cream compared to preoperative vaginal cleansing using a 10% povidone-iodine solution on postpartum infectious morbidity.
- Phase 4: studies an already-approved treatment
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 40, women only
You may be able to join if
- female participants with singleton pregnancies scheduled for elective cesarean sections at term, specifically between 37 and 40 weeks of gestation
- free from any medical disorders.
- The participants' ages ranged from 18 to 40 years
- body mass index (BMI) ranged from 18 to 30 kg/m2
You likely can't join if
- Cases of urgent or emergent CS.
- Abnormal vaginal secretion (bad smelling yellowish secretion, whitish cheesy discharge with pruritus, bloody discharge; etc…).
- Women with medical disorders such as pre-gestational diabetes, anemia, hypertension, preeclampsia, or immunosuppressant pregnant women.
- Women who had a skin infection adjacent to the operative site.
- Allergy to topical povidone-iodine or clindamycin
- Feverish patients or history of premature rupture of membranes or with placenta previa.
See the full eligibility criteria
- female participants with singleton pregnancies scheduled for elective cesarean sections at term, specifically between 37 and 40 weeks of gestation
- free from any medical disorders.
- The participants' ages ranged from 18 to 40 years
- body mass index (BMI) ranged from 18 to 30 kg/m2
- Cases of urgent or emergent CS.
- Abnormal vaginal secretion (bad smelling yellowish secretion, whitish cheesy discharge with pruritus, bloody discharge; etc…).
- Women with medical disorders such as pre-gestational diabetes, anemia, hypertension, preeclampsia, or immunosuppressant pregnant women.
- Women who had a skin infection adjacent to the operative site.
- Allergy to topical povidone-iodine or clindamycin
- Feverish patients or history of premature rupture of membranes or with placenta previa.
- patients lost during follow-up were excluded from the final analysis.
The study team makes the final eligibility decision.
Where it's taking place
- Banī Suwayf, Egypt
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 18 years to 40 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Banī Suwayf, Egypt. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.